REGISTERED NUMBER: |
REPORT OF THE DIRECTOR AND |
FINANCIAL STATEMENTS FOR THE PERIOD 9 NOVEMBER 2020 TO 30 SEPTEMBER 2021 |
FOR |
LONDON CANCER CARE LTD |
REGISTERED NUMBER: |
REPORT OF THE DIRECTOR AND |
FINANCIAL STATEMENTS FOR THE PERIOD 9 NOVEMBER 2020 TO 30 SEPTEMBER 2021 |
FOR |
LONDON CANCER CARE LTD |
LONDON CANCER CARE LTD (Registered number: 13005459) |
CONTENTS OF THE FINANCIAL STATEMENTS |
for the Period 9 NOVEMBER 2020 TO 30 SEPTEMBER 2021 |
Page |
Company Information | 1 |
Report of the Director | 2 |
Income Statement | 3 |
Balance Sheet | 4 |
Notes to the Financial Statements | 5 |
LONDON CANCER CARE LTD |
COMPANY INFORMATION |
for the Period 9 NOVEMBER 2020 TO 30 SEPTEMBER 2021 |
DIRECTOR: |
REGISTERED OFFICE: |
REGISTERED NUMBER: |
ACCOUNTANTS: |
The Annexe |
Minerva House |
Bordyke |
Tonbridge |
Kent |
TN9 1NR |
BANKERS: |
LONDON CANCER CARE LTD (Registered number: 13005459) |
REPORT OF THE DIRECTOR |
for the Period 9 NOVEMBER 2020 TO 30 SEPTEMBER 2021 |
The director presents his report with the financial statements of the company for the period 9 November 2020 to 30 September 2021. |
INCORPORATION |
The company was incorporated on 9 November 2020 and commenced trading on the same date. |
PRINCIPAL ACTIVITY |
The principal activity of the company in the period under review was that of Medical Consultants. |
DIVIDENDS |
An interim dividend of £ |
The total distribution of dividends for the period ended 30 September 2021 will be £ |
DIRECTOR |
The director, being eligible, offers himself for election at the forthcoming first Annual General Meeting. |
ON BEHALF OF THE BOARD: |
LONDON CANCER CARE LTD (Registered number: 13005459) |
INCOME STATEMENT |
for the Period 9 NOVEMBER 2020 TO 30 SEPTEMBER 2021 |
Notes | £ |
TURNOVER |
Administrative expenses |
OPERATING PROFIT | 4 |
Interest payable and similar expenses |
PROFIT BEFORE TAXATION |
Tax on profit | 5 |
PROFIT FOR THE FINANCIAL PERIOD |
LONDON CANCER CARE LTD (Registered number: 13005459) |
BALANCE SHEET |
30 SEPTEMBER 2021 |
Notes | £ | £ |
FIXED ASSETS |
Tangible assets | 6 |
CURRENT ASSETS |
Debtors | 7 |
Cash at bank and in hand |
CREDITORS |
Amounts falling due within one year | 8 |
NET CURRENT ASSETS |
TOTAL ASSETS LESS CURRENT LIABILITIES |
ACCRUALS AND DEFERRED INCOME |
NET ASSETS |
CAPITAL AND RESERVES |
Called up share capital | 9 |
Retained earnings | 10 |
SHAREHOLDERS' FUNDS |
The director acknowledges his responsibilities for: |
(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
The financial statements were approved by the director and authorised for issue on |
LONDON CANCER CARE LTD (Registered number: 13005459) |
NOTES TO THE FINANCIAL STATEMENTS |
for the Period 9 NOVEMBER 2020 TO 30 SEPTEMBER 2021 |
1. | STATUTORY INFORMATION |
LONDON CANCER CARE LTD is a |
2. | ACCOUNTING POLICIES |
Basis of preparing the financial statements |
Turnover |
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
Tangible fixed assets |
Taxation |
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
Current or deferred taxation assets and liabilities are not discounted. |
Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. |
Deferred tax |
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date. |
Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference. |
Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
3. | EMPLOYEES AND DIRECTORS |
£ |
Wages and salaries |
The average number of employees during the period was as follows: |
Medical Assistants |
4. | OPERATING PROFIT |
The operating profit is stated after charging: |
£ |
Depreciation - owned assets |
LONDON CANCER CARE LTD (Registered number: 13005459) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the Period 9 NOVEMBER 2020 TO 30 SEPTEMBER 2021 |
5. | TAXATION |
Analysis of the tax charge |
The tax charge on the profit for the period was as follows: |
£ |
Current tax: |
UK corporation tax |
Tax on profit |
UK corporation tax has been charged at 19% . |
6. | TANGIBLE FIXED ASSETS |
Plant and | Office |
machinery | equipment | Totals |
£ | £ | £ |
COST |
Additions |
At 30 September 2021 |
DEPRECIATION |
Charge for period |
At 30 September 2021 |
NET BOOK VALUE |
At 30 September 2021 |
7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
£ |
Trade Debtors |
Prepayments |
8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
£ |
Corporation Tax |
Accrued Expenses |
9. | CALLED UP SHARE CAPITAL |
Allotted, issued and fully paid: |
Number: | Class: | Nominal |
value: | £ |
Ordinary Shares | £1 | 100 |
100 Ordinary Shares shares of £1 each were allotted and fully paid for |
LONDON CANCER CARE LTD (Registered number: 13005459) |
NOTES TO THE FINANCIAL STATEMENTS - continued |
for the Period 9 NOVEMBER 2020 TO 30 SEPTEMBER 2021 |
10. | RESERVES |
Retained |
earnings |
£ |
Profit for the period |
Dividends | ( |
) |
At 30 September 2021 |